Inteligex Inc.

Inteligex Inc.

Private
Toronto, OntarioHealthcare & Life Scienceshttps://inteligexinc.com/

Last Round

Grant

Dec 10, 2025

Total Funding Raised

$105,000

Company Overview

Inteligex Inc. is a regenerative medicine company developing proprietary stem cell-based therapeutics to restore function in individuals with spinal cord injury and other diseases of the Central Nervous System.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Clinical Trials, Precision Medicine

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

stem cell therapyspinal cord injurySCIregenerative medicineneural stem cellscell therapybioengineered stem cellscentral nervous systemCNSclinical-stage biotechpersonalized medicinedisease progression predictionmedical AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Inteligex Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Inteligex Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantDec 10, 2025
AcceleratorJan 21, 2025

Inteligex Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 10, 2025

    Received grant from Give Back Health Innovation Foundation.

  • Jan 21, 2025

    $105K raised from Federal Economic Development Agency and Ontario Genomics.

Inteligex Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Inteligex Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Inteligex Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto, Ontario
Year Founded2018
Last FundingDec 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.